Kitov Pharmaceuticals Holdings Ltd (KTOV) Shares Down 1.7%
Shares of Kitov Pharmaceuticals Holdings Ltd (NASDAQ:KTOV) traded down 1.7% during trading on Monday . The company traded as low as $2.89 and last traded at $2.97, with a volume of 95,773 shares trading hands. The stock had previously closed at $3.02.
A number of analysts recently commented on the stock. Rodman & Renshaw restated a “buy” rating on shares of Kitov Pharmaceuticals Holdings in a research note on Saturday, May 14th. Zacks Investment Research upgraded shares of Kitov Pharmaceuticals Holdings from a “hold” rating to a “buy” rating and set a $3.25 price target on the stock in a research note on Wednesday, July 13th.
The firm’s market capitalization is $20.18 million. The stock’s 50 day moving average price is $3.08 and its 200 day moving average price is $4.03.
Kitov Pharmaceuticals Holdings Ltd is an Israel-based company that develops non-steroidal anti-inflammatory drugs that treat pain without raising blood pressure, thus avoiding the increased risk of heart attacks, strokes or death.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.